NASOPHARYNGEAL CANCER
Clinical trials for NASOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink Hard-to-Treat throat cancer
Disease control Not yet recruitingThis study tests whether adding a targeted drug (Becotatug Vedotin) to standard immunotherapy and chemoradiation can better shrink tumors and prevent cancer from returning in people with high-risk nasopharyngeal cancer. About 514 adults with advanced throat cancer will be randoml…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 06:13 UTC
-
New drug cocktail aims to stop High-Risk throat cancer in its tracks
Disease control Not yet recruitingThis phase 3 trial tests whether adding the drug anlotinib to standard chemoradiation and immunotherapy can help people with high-risk nasopharyngeal cancer live longer without the cancer coming back. About 412 adults aged 18-65 with advanced throat cancer will be randomly assign…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
Could less treatment be just as effective for advanced nose and throat cancer?
Disease control Not yet recruitingThis study compares a shorter course of the drug tislelizumab (given with chemotherapy and radiation) to a longer course in people with advanced nasopharyngeal cancer. The goal is to see if the shorter treatment works just as well at preventing the cancer from coming back or spre…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 05:50 UTC